Events in 2017

1 December 2017

HONG KONG (1 December 2017)- Hong Kong Biotech Horizon 2017 “Global Congress on Biotechnology: Diagnostics and Therapeutics” was successfully held during 22-26th November 2017 (Wed - Sun) at Charles K. Kao Auditorium, Hong Kong Science Park (HKSP).

The Congress was organized by Hong Kong Biotechnology Organization, co-organized by Hong Kong Science & Technology Parks Corporation and Asian Fund for Cancer Research and was funded by ITC. The Congress gathered numerous medical professionals, scientists, technologists and global leaders coming from worldwide who shared their insights on a broad and exciting programme comprising the latest developments in biotechnology.

The Congress was one of the official events to commemorate Hong Kong’s 20th Anniversary since its return to China. It was composed of speeches, symposia and public talks engaging the public community and raising awareness of the importance of science in society. In addition, this Global Congress offered a great opportunity to meet and mingle with an enthusiastic crowd of participants who are keen to obtain first-hand information on how to leverage the golden opportunity of China’s economic growth, the Guangdong-Hong Kong-Macao Greater Bay Area, and the Belt and Road Initiatives.

Contents of the five-day Congress were extremely fruitful and inspiring. A number of famous speakers were invited to deliver speeches. For example, Mrs. Fanny Chiu-Fun Law Fan, Chairman of Hong Kong Science Park Corporation; Prof. Lin He and Prof. Kwok-Fai So, Academician of Chinese Academy of Sciences; Prof. Bernard Roizman, Honorary President of Shenzhen International Institute for Biomedical Research (SIIBR); Mr. Chang-Wen Ke, Chairman and Chief Specialist of Guangdong Centre for Disease Control and Prevention; Dr. Jing Wang, Deputy Director of Division of Medical and Biological Measurement, National Institute of Metrology (NIM); Dr. Ru-Yi He, Chief Scientist of China Food and Drug Administration Evaluation Center etc.

Hundreds of participants attended Hong Kong Biotech Horizon 2017 “Global Congress on Biotechnology: Diagnostics and Therapeutics” and the Congress was viewed by over 2500 people from a number of countries through the live broadcast online. The active participation and the number of participants were indeed encouraging.

As the organizer of Hong Kong Biotech Horizon 2017 “Global Congress on Biotechnology: Diagnostics and Therapeutics”, Professor Albert Cheung-Hoi YU, Chairman of Hong Kong Biotechnology Organization, sincerely thanks all stakeholders including co-organizers, supporting organizations, sponsors and media partners involved in this Congress. Hong Kong Biotechnology Organization wishes to have opportunities to organize more biotechnology-related events in the coming future.

For more information, please visit the official website:
https://www.hkbio.org.hk/hkbh2017/index.php/tc/index.html and please stay tuned for Congress photo updates!

 

Prof. Albert YU, Chairman of HKBIO
delivered the opening address		 Mrs. Fanny LAW, Chairperson of Hong Kong Science and Technology Parks Corporation delivered the opening speech

 

Opening Ceremony
Prof. Albert YU, Mrs. Fanny LAW with invited speakers

 

Registrants and supporters were very attentive during the meetings

 

Mr. Nicholas YANG, Secretary for Innovation and Technology of HKSAR, met and awarded our invited speakers at 23rd evening

 

 

Speakers and registrants interacted and exchanged information during the coffee breaks

 

Gala dinner cum GuangDong - Hong Kong - Macao Greater Bay Area Biotechnology Alliance Inauguration Ceremony at 24th evening

 

 

Business Pitching Session on 25th November
We were very honoured to have Mr. Herbert CHIA, Venture Partner of Sequoia Capital China and Mr. Daniel SHI, CEO of 23Seed as the judges.

 

 

Business Pitching Session on 25th November
Top 5 Best Pitch Awards went to eNano Health Limited, METAFORA Biosystems, Liberand LLC, City University of Hong Kong, OncoSeek Ltd.

 

Public Lectures on 26th November

October 27, 2017

HONG KONG (31 October 2017) - 53 participants attended a visit to Futian, Shenzhen on 27 Oct 2017 (Friday) jointly organized by Hong Kong Biotechnology Organization (香港生物科技協會), Hong Kong Industry University Research Collaboration Association (香港產學研合作促進會), The Chinese Manufacturers’ Association of Hong Kong - Biotechnology Industry Committees (中華廠商會生物科技行業委員會) and Smart City Consortium (智慧城市聯盟). Participants included Professor Yuk-Lam Lo, Executive Committee Member of The Chinese Manufacturers’ Association of Hong Kong; Professor Christopher Cheng, Managing Director of Hong Kong Institute of Biotechnology; Dr. Samson Tam, President of Hong Kong Industry University Research Collaboration Association; Dr. Anny Wong, Head of Mainland Collaboration & Business Development, HKSTP Corporation; Professor Albert Yu, Chairman of Hong Kong Biotechnology Organization etc. The visit provided precious opportunity for biotech stakeholders in Hong Kong to understand and investigate the future development and cooperation plan of Futian and The Lok Ma Chau Loop, thereby inviting them to assimilate into the spirit and development of Biotechnology at China’s Greater Bay Area, with a view of sharing the latest biotechnology information and to get business opportunities amongst them.

The ‘Greater Bay Area’ refers to the Chinese government's scheme to link the cities of Hong Kong, Macau, Guangzhou, Shenzhen, Zhuhai, Foshan, Zhongshan, Dongguan, Huizhou, Jiangmen and Zhaoqing into an integrated economic and business hub. Under this scheme, The Lok Ma Chau Loop in Hong Kong and Futian area in Shenzhen will be the main hub for innovation and technology development. At the latest policy address, HKSAR Chief Executive Carrie Lam emphasized on Hong Kong’s innovation and technology development: HKSAR Government will take an active role in fostering collaboration in the Greater Bay Area and in constructing the international Inno-tech centre.

During the visit, officials from Futian area government were invited to give speeches to introduce their future development plan and arrangements. “Shenzhen’s miraculous growth in the past 30 years could not have been possible without Hong Kong. Today as innovation-driven Shenzhen powers ahead, the need for strong alliance and collaboration with Hong Kong is even higher,” remarked Dr. Liu Zhi-Yong, Deputy District Mayor of Futian District People’s Government of Shenzhen Municipality.

“Shenzhen government provides ample support for innovation and the nurturing of talents. Both the extent and the strength of support is incredible and unparalleled….If you have a promising project, Shenzhen will welcome you with open arms… Speaking from my own experience as an overseas-Chinese returnee building a biotech start-up from scratch in China, Shenzhen’s effort in helping emerging industry grow can’t be matched by anywhere else in the world,” stated Professor Grace Zhou, Chairman of Shenzhen International Institute for Biomedical Research (SIIBR).

“We must leverage Hong Kong’s unique advantage in its rich experience in corporate governance to effectively realize the ‘One Belt One Road’ initiative. Futian takes a lead in potentiating high-technology collaboration between Shenzhen and Hong Kong,” commented Professor Albert Yu, Chairman of Hong Kong Biotechnology Organization.

Free Joomla! template by Age Themes